CervoMed Inc (CRVO) Posted -118.68% Profit Margin Last Year—Can It Hold Up?
D. Boral Capital has recently reduced CervoMed Inc (CRVO) stock to Hold rating, as announced on Today, according to Finviz. Earlier, on December 6, 2024, ROTH MKM had initiated the stock to Buy, setting a price target of $45. H.C. Wainwright also initiated Buy rating with a price target of $42. Additionally, Chardan Capital Markets […]
HWH International Inc (HWH) Reported a -240.81% Operating Margin Last Year—What’s the Real Story?
HWH International Inc (HWH) Stock Trading Recap On Tuesday, HWH International Inc (HWH) stock saw a decline, ending the day at $0.62 which represents a decrease of $-0.39 or -38.61% from the prior close of $1.01. The stock opened at $1.19 and touched a low of $0.62 during the day, reaching a high of $1.44. […]
What’s Driving Canoo Inc (GOEV) Stock’s -67.19% Plunge Over the Past Month?
R. F. Lafferty has recently reduced Canoo Inc (GOEV) stock to Hold rating, as announced on May 15, 2024, according to Finviz. Earlier, on April 17, 2024, The Benchmark Company had initiated the stock to Buy, setting a price target of $5. Wedbush also initiated Outperform rating with a price target of $4. Additionally, Stifel […]
Why Did Momentus Inc (MNTS) Stock Tumble -26.79% to $0.41?
Evercore ISI has recently initiated Momentus Inc (MNTS) stock to Underperform rating, as announced on July 5, 2022, according to Finviz. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment. Momentus Inc (MNTS) Stock Trading Recap On Tuesday, Momentus Inc (MNTS) stock saw a decline, ending […]
Analysts Predict a $2.50 Target for Esperion Therapeutics Inc (ESPR) Stock—What Could Drive It There?
BofA Securities has recently reduced Esperion Therapeutics Inc (ESPR) stock to Underperform rating, as announced on June 20, 2024, according to Finviz. Earlier, on January 3, 2024, BofA Securities had reduced the stock from a Buy to Neutral. JP Morgan also resumed Neutral rating. Additionally, Northland Capital raised Market Perform rating on August 1, 2023. […]
What’s Behind the -25.00% Drop in Algorhythm Holdings Inc (RIME) Stock? Find Out Now!
Algorhythm Holdings Inc (RIME) Stock Trading Recap On Tuesday, Algorhythm Holdings Inc (RIME) stock saw a decline, ending the day at $0.09 which represents a decrease of $-0.03 or -25.00% from the prior close of $0.12. The stock opened at $0.1 and touched a low of $0.09 during the day, reaching a high of $0.1. […]
CERo Therapeutics Holdings Inc (CERO) Stock: More Resilient Than It Appears
CERo Therapeutics Holdings Inc (CERO) Stock Trading Recap On Tuesday, CERo Therapeutics Holdings Inc (CERO) stock saw a decline, ending the day at $0.09 which represents a decrease of $-0.02 or -18.18% from the prior close of $0.11. The stock opened at $0.11 and touched a low of $0.08 during the day, reaching a high […]
How Does Sutro Biopharma Inc (STRO) Stack Up Against Its Industry Peers?
BofA Securities has recently initiated Sutro Biopharma Inc (STRO) stock to Buy rating, as announced on May 8, 2024, according to Finviz. Earlier, on November 9, 2023, Deutsche Bank had initiated the stock to Buy, setting a price target of $12. Oppenheimer also initiated Outperform rating with a price target of $10. Additionally, Wells Fargo […]
Satellogic Inc (SATL) Stock: More Strategic Than Meets the Eye
Satellogic Inc (SATL) Stock Trading Recap On Tuesday, Satellogic Inc (SATL) stock saw a decline, ending the day at $3.98 which represents a decrease of $-0.76 or -16.03% from the prior close of $4.74. The stock opened at $4.24 and touched a low of $3.62 during the day, reaching a high of $4.43. The volume […]
BigBear.ai Holdings Inc (BBAI) Stock: Analyzing Its Quiet Power
Cantor Fitzgerald has recently initiated BigBear.ai Holdings Inc (BBAI) stock to Overweight rating, as announced on January 9, 2024, according to Finviz. Earlier, on October 2, 2023, TD Cowen had initiated the stock to Market Perform, setting a price target of $2. H.C. Wainwright also initiated Buy rating with a price target of $4. Additionally, […]
